Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Walenga

Showing results (101-110 of 196) with videos related to

Pageof 20
Sort By:
Thrombosis Research|July 1, 1988
The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activityJ M Walenga, L Bara, M Petitou, et al.
The Annals of Thoracic Surgery|April 1, 1996
Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operationsC Primack, J M Walenga, M J Koza, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Impact of biotechnology in the diagnostic and therapeutic management of cardiovascular disordersJ Fareed, D Hoppensteadt, L Iyer, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin)J Fareed, J M Walenga, D Hoppensteadt, et al.
Thrombosis Research|January 15, 1992
Influence of recombinant hirudin and unfractionated heparin on thrombin and factor Xa generation in extrinsic and intrinsic activated systemsB Kaiser, J Fareed, D Hoppensteadt, et al.
Thrombosis Research|May 15, 1993
A simulated post-angioplasty low molecular weight heparin schedule in a non-human primate modelP Bacher, O Iqbal, B Lojewski, et al.
Thrombosis Research|April 1, 1997
Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharideJ M Walenga, W P Jeske, L Bara, et al.
The Medical Clinics of North America|July 1, 1998
Antithrombin agents as anticoagulants and antithrombotics. Implications in drug developmentJ Fareed, D Callas, D A Hoppensteadt, et al.
Haemostasis|January 1, 1991
Laboratory assays for the evaluation of recombinant hirudinJ M Walenga, D Hoppensteadt, M Koza, et al.
Seminars in Thrombosis and Hemostasis|June 5, 1999
Laboratory tests for the diagnosis of heparin-induced thrombocytopeniaJ M Walenga, W P Jeske, A R Fasanella, et al.
Pageof 20

Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
Thrombosis Research|July 1, 1988
The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activityJ M Walenga, L Bara, M Petitou, et al.
The Annals of Thoracic Surgery|April 1, 1996
Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operationsC Primack, J M Walenga, M J Koza, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Impact of biotechnology in the diagnostic and therapeutic management of cardiovascular disordersJ Fareed, D Hoppensteadt, L Iyer, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin)J Fareed, J M Walenga, D Hoppensteadt, et al.
Thrombosis Research|January 15, 1992
Influence of recombinant hirudin and unfractionated heparin on thrombin and factor Xa generation in extrinsic and intrinsic activated systemsB Kaiser, J Fareed, D Hoppensteadt, et al.
Thrombosis Research|May 15, 1993
A simulated post-angioplasty low molecular weight heparin schedule in a non-human primate modelP Bacher, O Iqbal, B Lojewski, et al.
Thrombosis Research|April 1, 1997
Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharideJ M Walenga, W P Jeske, L Bara, et al.
The Medical Clinics of North America|July 1, 1998
Antithrombin agents as anticoagulants and antithrombotics. Implications in drug developmentJ Fareed, D Callas, D A Hoppensteadt, et al.
Haemostasis|January 1, 1991
Laboratory assays for the evaluation of recombinant hirudinJ M Walenga, D Hoppensteadt, M Koza, et al.
Seminars in Thrombosis and Hemostasis|June 5, 1999
Laboratory tests for the diagnosis of heparin-induced thrombocytopeniaJ M Walenga, W P Jeske, A R Fasanella, et al.
Pageof 20